| For: | D'Ovidio V, Meo D, Viscido A, Bresci G, Vernia P, Caprilli R. Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. World J Gastroenterol 2011; 17(14): 1831-1835 [PMID: 21528055 DOI: 10.3748/wjg.v17.i14.1831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i14/1831.htm |
| Number | Citing Articles |
| 1 |
Caroline Schultheiß, René Weischenberg, Andrea Herrmann, Bernhard Haller, Roland M. Schmid, Wolfgang Reindl, Wolfgang Huber. Dose‐Intensified Granulocyte‐Monocyte Apheresis in Therapy Refractory Ulcerative Colitis. Artificial Organs 2015; 39(2) doi: 10.1111/aor.12329
|
| 2 |
Daniel Vasile Balaban, Mariana Jinga. Crohn’s Disease Recent Advances. 2021; doi: 10.5772/intechopen.93605
|
| 3 |
Axel U Dignass, Ayesha Akbar, Joan-Ramon Grífols, Eugeni Domènech. Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective. World Journal of Gastroenterology 2021; 27(10): 908-918 doi: 10.3748/wjg.v27.i10.908
|
| 4 |
Rodolfo Sacco, Antonio Romano, Alessandro Mazzoni, Marco Bertini, Graziana Federici, Salvatore Metrangolo, Giuseppe Parisi, Cecilia Nencini, Celeste Giampietro, Michele Bertoni, Emanuele Tumino, Fabrizio Scatena, Giampaolo Bresci. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: A prospective observational study. Journal of Crohn's and Colitis 2013; 7(12) doi: 10.1016/j.crohns.2013.06.012
|
| 5 |
Axel Dignass, Ayesha Akbar, Daniel C. Baumgart, Gilles Bommelaer, Guillaume Bouguen, Guillaume Cadiot, Anton Gillessen, Jean-Charles Grimaud, Ailsa Hart, Syed Hoque, Richard Makins, Christophe Michiels, Jacques Moreau, Purushothaman Premchand, Wolfgang Ramlow, Stefan Schanz, Sreedhar Subramanian, Christian von Tirpitz, Bruno Bonaz. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis. Scandinavian Journal of Gastroenterology 2018; 53(4) doi: 10.1080/00365521.2018.1447598
|
| 6 |
Yoh Ishiguro, Toshihide Ohmori, Ken Umemura, Masahiro Iizuka. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study. Therapeutic Apheresis and Dialysis 2021; 25(4) doi: 10.1111/1744-9987.13594
|
| 7 |
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Satoshi Tamura, Ryosuke Takano, Shinya Tani, Satoshi Osawa, Ken Sugimoto, Takahiro Shimoyama, Hiroyuki Hanai. A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. Clinical and Translational Gastroenterology 2018; 9(7) doi: 10.1038/s41424-018-0037-0
|
| 8 |
Marianne Hupé, Guillaume Bouguen, Anthony Buisson, Cecilia Landman, Mathieu Uzzan, Stéphane Nancey, Guillaume Cadiot, Cyrielle Gilletta, Maëva Charkaoui, Lucas Guillo, Anne Wampach, Michael Collins, Romain Altwegg, Franck Cholet, Aurélien Amiot. Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study. Clinics and Research in Hepatology and Gastroenterology 2026; 50(8) doi: 10.1016/j.clinre.2026.102889
|
| 9 |
Ryo Nakano, Ryuichi Iwakiri, Yuji Ikeda, Tomoya Kishi, Nanae Tsuruoka, Ryo Shimoda, Yasuhisa Sakata, Kanako Yamaguchi, Kazuma Fujimoto. Factors affecting short‐ and long‐term effects of leukocyte removal therapy in active ulcerative colitis. Journal of Gastroenterology and Hepatology 2013; 28(2) doi: 10.1111/jgh.12049
|
| 10 |
Renata D’Incà, Giacomo Carlo Sturniolo, Giorgia Hatem, Tiziana Tison, Piero Marson, Edoardo Savarino, Chiara De Cassan. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. World Journal of Gastroenterology 2014; 20(45): 17155-17162 doi: 10.3748/wjg.v20.i45.17155
|
| 11 |
José Luis Cabriada. Aféresis en enfermedad inflamatoria intestinal. ¿Una opción válida?. Gastroenterología y Hepatología 2012; 35(1) doi: 10.1016/j.gastrohep.2011.10.005
|
| 12 |
J. L. Cabriada, E. Domènech, N. Ibargoyen, V. Hernández, J. Clofent, D. Ginard, I. Gutiérrez-Ibarluzea, J. Hinojosa. Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry. Journal of Gastroenterology 2012; 47(4) doi: 10.1007/s00535-011-0499-2
|